Clinical Trial Update: Study to Evaluate the Efficacy and Safety of AHB-137 in Treatment-naive Participants With Chronic Hepatitis B (CHB) [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating AHB-137 in treatment-naive adults with chronic hepatitis B is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• AHB-137

Snippet

Sponsor: Ausper Biopharma Co., Ltd. | Conditions: Chronic Hepatitis B | Phase 2 | Status: ACTIVE_NOT_RECRUITING